What's Next in Alzheimer's Disease Research and Treatment
Live Webinar: November 4, 2026, 1 pm ET, 10 am PT
Despite recent progress with the first approved anti-amyloid therapies, Alzheimer’s disease remains one of neuroscience’s most pressing challenges. Key questions about the condition’s underlying biology, its disproportionate impact on minoritized communities, and how to detect it earlier are active research areas. Closing these gaps will require new biomarkers, a clearer picture of tau pathology, and treatment strategies that look beyond amyloid alone.
Join Biocompare on November 4, 2026 at 1 pm ET / 10 am PT for a live webinar featuring researchers Charisse Winston and Alysa Kasen. Winston will discuss how neuronal extracellular vesicles shape disease risk in underrepresented populations and their promise as accessible diagnostic biomarkers, while Kasen will present on the structural biology of tau and how it drives seeding activity in neurodegeneration.
In this webinar, you’ll learn:
- How neuronal extracellular vesicles isolated from blood and saliva can serve as accessible, early diagnostic biomarkers for Alzheimer’s disease and related dementias
- How tau filament core structure and post-translational modifications within the “fuzzy coat” influence seeding competence and biological activity
- What these structural and molecular insights reveal about the mechanisms driving tau-related neurodegeneration
Register today to gain valuable insights into the latest advances in Alzheimer’s disease biomarker discovery and tau biology.
FILL THE FORM BELOW
© An Imprint of coreinteltech | All rights reserved | Privacy Policy